期刊文献+

环丙沙星联用磷霉素抗尿路感染耐药铜绿假单胞菌的协同作用体外研究 被引量:4

On the In Vitro Synergistic Effect of Ciprofloxacin Combined with Fosfomycin against Drug-Resistant Pseudomonas Aeruginosa Isolates from Urinary Tract Infections
下载PDF
导出
摘要 目的观察环丙沙星和磷霉素联合应用抗尿路感染耐药铜绿假单胞菌的体外协同作用。方法采用常规方法进行细菌分离和菌种鉴定。最低抑菌浓度(MIC)测定采用微量肉汤稀释法,联合抑菌浓度指数(FICI)测定采用棋盘法。结果 82株耐环丙沙星铜绿假单胞菌中,环丙沙星和磷霉素联合应用对22株细菌有协同抗菌作用,占26.83%。急性杀菌作用中,选取环丙沙星和磷霉素联合应用后协同抗菌作用和环丙沙星MIC降低均最明显的铜绿假单胞菌P34和P58作为研究对象,结果在药物处理8 h时,环丙沙星和磷霉素联合处理组的细菌数明显低于两种药物单独处理组。浊度试验结果显示,药物处理3 h后,联合用药组与单独用药组细菌浊度出现明显差异。结论环丙沙星和磷霉素联合应用不但具有抗耐环丙沙星铜绿假单胞菌的协同作用,且具有较强的杀菌效果和溶菌作用。 Objective To investigate the in vitro synergistic effect of eiprofloxacin combined with fosfomycin on ciprofloxacin-resistant Pseudomonas aeruginosa clinical isolates from urinary tract infections. Methods The isolation and identification of Pseudomonas aeruginosa were performed by using the traditional procedures. The minimum inhibitory concentration(MIC) testing was determined by using the mierodilution broth method. The fractional inhibitory concentration index(FICI) was tested by using the checkerboard method. Results Among the 82 ciprofloxacin-resistant Pseudomonas aeruginosa isolates, the synergistic effect of eiprofloxacin combined with fosfomycin was observed in 22 strains(26.83% ). In the acute bactericidal effect experiments, Pseudomonas aeruginosa isolates P34 and P58 as the most obvious synergistic effect and the reduced MIC of ciprofloxacin were selected as the research subjects. The results showed that the viable c, ell count at 8 h after medication treatment in the ciprolloxacin and fosfomycin combination treatment group was significantly fewer than that of the single drug treatment group. The turbidity test results showed that the significant difference at 3 h after medica- tion treatment was observed between the ciprofloxacin and fosfomycin combination treatment group and the single drug treatment group. Conclusion The combination of ciprofloxacin and fosfomycin not only induces a synergistic eftect on ciprofloxacin-resistant Pseu- domonas aeruginosa strains, but also has a strong bactericidal effect and bacteriolytic effect.
出处 《中国药业》 CAS 2015年第2期36-38,共3页 China Pharmaceuticals
关键词 尿路感染 环丙沙星 磷霉素 铜绿假单胞菌 协同作用 urinary tract infections ciprofloxacin fosfomycin Pseudomonas aeruginosa synergistic effect
  • 相关文献

参考文献15

  • 1Mittal R, Aggarwal S, Sharma S, et al. Urinary tract infections caused by Pseudomonas aeruginosa: a minireview [J]. J Infect Public Health,2009, 2(3):101-111.
  • 2Moore KN, Day RA, Albers M. Pathogenesis of urinary tract infections: a review [ J ]. J Clin Nuts, 2002,11 (5) : 568 - 574.
  • 3Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens [ J ]. Dis Mon, 2003,49 (2) : 71 - 82.
  • 4Coban AY, Ekinci B, Durupinar B. A multidrug efflux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates[J].Chemotherapy, 2004,50 (1) : 22 - 26.
  • 5Drago G, Vecchi ED, Nicola L, et al. Activity of levofloxacin and ciproloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-lazobactam and amikacin against different Pseudomonas aeruginosa phertoypes and Actinetobader spp[ J ]. Chemotherapy, 2004, 50(4): 202 -210.
  • 6Karageorgopoulos DE, Wang R, Yu XH, et al. Fosfomycin: evaluation of the pullished evidence on the emergence of antimicrobial resistance in Gram - negalive pathogens . J Antimierob Chernother, 2012, 67(2): 255 - 268.
  • 7Falagas M E, Maraki S, Karageorgopoulos DE, et al. Antimicrobial suscepti- bility of Gram - positive non - urinary isolates to foslbmycin [ J].Int J Antinlierob Agents, 2010,35 (5) : 497 - 499.
  • 8Cat Y, Fan Y, Wang R, el al. Synergistic effects of aminoglycosides and fosfomyein on Psedomonas acruginoa in vitro anti biofilm infections in a vat model [ J ]. J A ntimierob Chemother, 2009,64 (3) : 563 - 566.
  • 9Figuevedo VM, Neu IIC. Synergy of ciprofloxacin with fosfomyein in vitro against Pseudomonas isolates from patients with cystic fibrosis[J]. J Antimierob Chemother, 1988,22 (1):41 -50.
  • 10Yasmin F, Akhtar N, Hameed A. In vitro synergistic effect of eiprofloxaein with aminoglyeosides against multidrug resistant- Pseudormnas azeruginosa[J]. Pak J Pharm Sci,2013,26(5): 1 041 - 1 044.

二级参考文献1

共引文献7

同被引文献72

  • 1高福仁,张艳霞.磷霉素庆大霉素治疗急性婴幼儿菌痢疗效观察[J].实用全科医学,2005,3(1):45-45. 被引量:5
  • 2佟金平,王镇山,薛欣,顾俊明.磷霉素与14种抗菌药物分别联用的体外抗菌活性研究[J].中国抗生素杂志,2005,30(4):233-237. 被引量:26
  • 3范燕,刘茹,王睿.磷霉素与氨基糖苷类药物联合应用的研究进展[J].中国药物警戒,2007,4(3):171-175. 被引量:9
  • 4Sun F, Qu F, Ling Y, et al. Biofilm-associated infections: antibiotic resistance and novel therapeutic strategies[J]. Future Microbiol, 2013,8(7) : 877.
  • 5Louie A, Bied A, Fregeau C, et al. Impact of different carbapenems and regimens of administration on resistance emergence for three isogenic Pseudomonas aeruginosa strains with differing mechanisms of resistance[J]. Antimi- crob Agents Chemother, 2010,54(6) : 2 638.
  • 6Yousefi S, Farajnia S, Nahaei MR, et al. Detection of metallo-β-lactamase-encoding genes among clinical iso- lates of Pseudomonas aeruginosa in northwest of Iran[J]. Diagn Microbiol Infect Dis, 2010,68 (3) : 322.
  • 7Yamada S, Hyo Y, Ohmori S, et al. Role of ciprofloxa- cin in its synergistic effect with fosfomycin on drug-resis- tant strains of Pseudomonas aeruginosa[J]. Chemothera- py, 2007,53(3) :202.
  • 8Odds FC. Synergy, antagonism, and what the chequerbo- ard puts between them[J]. J Antimicrob Chemother, 2003, 52(1): 1.
  • 9Kunakonvichaya B, Thirapanmethee K, Khuntayapom P, et al. Synergistic effects of fosfomycin and carbapen- ems against carbapenem-resistant Pseudomonas aerugino- sa clinical isolates[J], lnt J Antimicrob Agents, 2015, 45 (5):556.
  • 10Clinical Laboratory Standards Institute. Performance stan- dards for antimicrobial susceptibility testing: twentieth in- formational supplement[S]. 2010-01-30.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部